2nd National Symposium : BASIC ASPECTS OF VACCINES

The Walter Reed Army Institute of Research (WRAIR), Washington, DC , Uniformed Services University of the Health Sciences (USUHS), Bethesda, MD
April 30 - May 2, 1997

Invited Speakers:

• ELI SERCARZ (University of California at Los Angeles)



• ALESSANDRO SETTE (Cytel, Inc., San Diego, CA)



• MARTIN KAST (Loyola University Cancer Center)



• PETER PALESE (Mont Sinai Medical School)



• PETER COLLINS (NIAID, NIH)



• HARRIET L. ROBINSON (U. Mass. Medical School)



• MAURICE HILLEMAN (Merck Inst. Therap. Res.)



• TIM R. MOSMANN (University of Alberta)



• RALPH M. STEINMAN (Rockfeller University)



• KENNETH ROCK (Dana Farber Cancer Institute)



• KEVIN KILLEEN (Virus Res. Institute)



• HARRY B. GREENBERG (Stanford University School of Medicine)



• HOWARD L. WEINER (Harvard University School of Medicine)



• JOHN ROBBINS (NICHD, NIH)



• STEPHEN JOHNSTON (U. Texas Southwestern Med. Center)



• CHARLES ARNTZEN (Boyce Thompson Inst. for Plant Res., Inc.)



• GORDON DOUGAN (Imperial College of Science, Technology and Medicine)

Program:
The purpose of this symposium is to provide a broadly based interactive forum for discussion of some of the most
important current issues in basic immunology and vaccinology. Each sesion will be in the form of a minisymposium
organized and conducted by the chairperson, with speakers selected both by invitation and from among applicants
to the meeting.

Wednesday, 30 April 1997

0830-1230: PEPTIDE AND PROTEIN ANTIGENS (Jay Berzofsky, Chair)

• Jay Berzofsky (NCI, NIH), Introduction



• Jay Berzofsky, Improving Peptide Vaccines and T-Cell Immunotherapy by
  Structural Epitope Enhancement and Selection of T-Cell Avidity



• Eli Sercarz (UCLA), Interactions of Determinants in Inducing an Appropriate
  Immune Response



• Alessandro Sette (Cytel, Inc., San Diego, CA), HLA Supermotifs and Epitope Immunodominance in
  development of Peptide-based CTL Vaccines



• Martin Kast (Loyola U. Cancer Center), Immunomodulation of CTL Responses by Peptides
  

• Bernard Moss (NIAID, NIH), Overview: Live Virus Vectors



• Peter Palese (Mount Sinai Medical School), Genetic Engineering of Negative Strand RNA Viruses:
  Influenza Virus



• Peter Collins (NIAID, NIH), Application of Genetic Engineering to Vaccine Development
  for Respiratory Synctial Virus



• Harriet L. Robinson (U. Mass. Medical School), DNA Vaccines: Influenza, Measles and HIV Models
  

• Speaker: Maurice Hilleman (Merck Inst. Therap. Res.), Viruses, Vaccines, and Vaccinology

• Carl R. Alving (WRAIR), Overview: Adjuvant Strategies



• Tim R. Mosmann (U. Alberta), T Cells and Cytokines



• Ralph M. Steinman (Rockefeller U.), Antigen Presentation in Vivo: Role of Dendritic Cells
  


• Kenneth Rock (Dana Farber Cancer Inst.), Targeting Vaccine antigens for Presentation by Phagocytes in Vivo
  

• Martin F. Kagnoff (U. Calif, San Diego Sch Med), Overview: Special Features of the Mucosal Immune System



• Kevin Killeen (Virus Res Inst), The Design of Vaccines for Mucosal Surfaces - The Cholera Toxin and Salmonella Paradigms



• Harry B. Greenberg (Stanford U Sch Med), Development of Vaccines for Infectious Diarrheas: The Rotavirus Paradigm



• Howard L. Weiner (Harvard U Med Sch), Oral Tolerance and Its Implications for Vaccine Development and the Treatment of Autoimmune Disease
  

• John Robbins (NICHD, NIH), Polysaccharide-Protein Carrier Conjugate Vaccines:
  Future Directions



• Stephen Johnston (U. Texas Southwestern Med. Center), DNA-Based Vaccines



• Charles Arntzen (Boyce Thompson Inst. for Plant Res., Inc.), Expression of Vaccine Antigens in Plants



• Gordon Dougan (Imperial College of Science, Co-Administration of Mutant LT to Adjuvant the Serum and
  Mucosal Immune Response Following Mucosal Immunization with Protein Antigens



• Myron M. Levine (Center for Vaccine Development, U. MD at Baltimore), Bacterial Live Vector Vaccines

Registration :
Registration fee includes documentation (conference publications), opening reception, continental breakfast, refreshments, and banquet.
Acceptance will be finalized upon receipt of the registration fee.

--------------------------------------------------------------------------------------------------

NAME________________________________________POSITION _________________________________________

AFFILIATION___________________________________________________________________________________

ADDRESS______________________________________________________________________________________

_______________________________________________________________________________________________

_______________________________________________________________________________________________

TELEPHONE ( ____ )______________FAX ( ____ )______________POSTER: Yes___________No_______________

___ Please send a brochure for the AAP/ASCI/AFCR Biomedicine 97 meeting

--------------------------------------------------------------------------------------------------

The registration fee also entitles attendees to pay the reduced members-only rate for attendance at the

AAP/ASCI/AFCR BIOMEDICINE 97 MEETING ON APRIL 25-28, 1997



Posted by Dr. Jean M. Muderhwa, Department of Membrane Biochemistry, WRAIR, Washington (DC)
 


Deadline for Abstracts: March 15, 1997

Email for Requests and Registration: symposium@wrair-emh1.army.mil

Posted by: Jean M. Muderhwa, Ph.D. Host: 160.151.232.196 date: October 16, 96 19:14:07


Generated by meetings and positions 1.0 by Kai Garlipp